Article Details
Retrieved on: 2025-02-04 15:40:34
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article explores using chitosan nanoparticles to target PD1/PD-L1 and CTLA-4 pathways in colorectal cancer. Chitosan, through immune-modulating properties, is linked with T cell regulation, apoptosis, and immune checkpoints like PD-L1, influencing cancer therapy.
Article found on: www.nature.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here